Enrolling Clinical Trials
Early rehabilitation in critically ill patients in the intensive care unit
Early rehabilitation using functional electrical stimulation assisted supine cycling effect on muscle mass, strength, biomarkers, and functional outcomes as compared with conventional exercise and early mobilization alone in critically ill patients in the intensive care unit
For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].
Dr. Timothy Evans Harsha Deoghare, DPT Paul Smith, DPT
Division of Pulmonary and Associate Dean of Research Acute Care Rehab Services
Critical Care Medicine Western University Community Health System
UCSF Fresno
Is Routine Packing of Cutaneous Abscesses Necessary?
Examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further inte Examine patients undergoing incision and drainage of cutaneous abscesses to determine if routine packing of the abscess cavity affects the need for further interventions
For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected] or Ruchi Ruwal at [email protected].
Dr. Michael Darracq
Emergency Medicine
UCSF Fresno
Efficacy of ED Provider-Performed Dental Block for Pain Relief in ED Patients Presenting with Dental Pain
For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected] or Ruchi Ruwal at [email protected].
Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno
Combat Gauze© in Trauma Patients: An observational study of a hemostatic agent versus plain gauze in the ER setting
For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected] or Ruchi Ruwal at [email protected].
Dr. Danielle Campagne
Emergency Medicine
UCSF Fresno
Vicryl Rapide versus Nonabsorbable Suture in Repair of Simple Traumatic Extremity and Trunk Lacerations in Adult Patients
For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at jannet [email protected] or Ruchi Ruwal at [email protected].
Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno
History, Symptomatology, and Physical Exam Features and Under-and Overtreatment of GC and UTI in Male Urethritis Patient in the ED
For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at [email protected] or Ruchi Rawal at [email protected].
Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno
Concordance of Patients UTI Symptoms with Practitioner Perception of UTI Symptoms
For more information about this trial, please contact the corresponding research coordinator, Jannet Castaneda at [email protected] or Ruchi Rawal at [email protected].
Dr. Brian Chinnock
Emergency Medicine
UCSF Fresno
A Phase III Randomized Trial of Steroids + TKI Induction with Chemotherapy or Blinatumomab for Newly Diagnosed BCR-ABL-positive ALL in Adults
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno
The CompassHER2 Trials (Comprehensive Use of Pathologic Response Assessment to Optimize Therapy in HER2-Positive Breast Cancer) CompassHER2 Residual Disease (RD), a Double-Blinded, Phase III Randomized Trial of T-DM1 Compared With T-DM1 and Tucatinib
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Constance Stoehr
Division of Hematology/Oncology
UCSF Fresno
A Randomized Phase 3 Study of MRTX849 in Combination with Cetuximab Versus Chemotherapy in Patients with Advanced Colorectal Cancer with KRAS G12C Mutation with Disease Progression On or After Standard First-Line Therapy
For more information about this trial, please contact Alejandra Valencia at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
A Phase 1B/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study of Tazemetostat or Placebo in Combination with Lenalidomide Plus Rituximab in Subjects with Relapsed/Refractory Follicular Lymphoma
For more information about this trial, please contact Alejandra Valencia at [email protected]
Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno
Obinutuzumab, Ibrutinib, and Venetoclax for the Treatment of Previously Untreated Stage II-IV Follicular Lymphoma
For more information about this trial, please contact Lizbeth Gasga at [email protected]
Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno
A Phase II Study of Ipilimumab, Cabozantinib, and Nivolumab in Rare Genitourinary Cancers (ICONIC)
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
A Phase II Study, Evaluating the Efficacy of Montelukast (Singulair) in Reducing the Incidence and Severity of Monoclonal Antibodies Associated Infusion Reactions
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Mohameed Bukari
Division of Hematology/Oncology
UCSF Fresno
(MAGNETISMM-5) An Open-Label, 3-Arm, Multicenter, Randomized Phase 3 Study to Evaluate the Efficacy and Safety of Elranatamab (PF-06863135) Monotherapy and Elranatamab + Daratumumab Versus Daratumumab + Pomalidomide + Dexamethasone in Participants with Relapsed/Refractory Multiple Myeloma Who Have Received at Least 1 Prior Line of Therapy Including Lenalidomide and A Proteasome Inhibitor
For more information about this trial, please contact Lizbeth Gasga at [email protected]
Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno
A Phase 1/2 Study of BMS-986340 as Monotherapy and in Combination with Nivolumab or Docetaxel in Participants with Advanced Solid Tumors
For more information about this trial, please contact Alejandra Valencia at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
Improving Survivorship Care for Older Adults after Chemotherapy
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Haifaa Abdulhaq
Division of Hematology/Oncology
UCSF Fresno
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
A Randomized Phase III Trial for Surgically Resected Early Stage Non-Small Cell Lung Cancer: Crizotinib Versus Observation for Patients with Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
A Randomized Phase III, Two-Arm Trial of Paclitaxel/ Carboplatin/ Maintenance Versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
For more information about this trial, please contact Alejandra Valencia at [email protected]
Dr. Trung “Tim” Nguyen
Division of Gynecologic Oncology
UCSF Fresno
A Phase III Double-Blind, Randomised, Placebo-Controlled Study Assessing the Efficacy and Safety of Capivasertib + Docetaxel Versus Placebo + Docetaxel as Treatment for Patients with Metastatic Castration Resistant Prostate Cancer (mCRPC)
For more information about this trial, please contact Alejandra Valencia at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of The Primary Tumor in Metastatic Prostate Cancer
For more information about this trial, please contact Alejandra Valencia at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab vs. VEGF TKI Cabozantinib with Nivolumab; a Phase III in Metastatic Untreated Renal Cell Cancer (PDIGREE)
For more information about this trial, please contact Kelly Meehan at [email protected]
Dr. Uzair Chaudhary
Division of Hematology/Oncology
UCSF Fresno
Prevalence of non-alcoholic fatty liver disease in school-age children in Central Valley and the effect of nutritional intervention on the disease trajectory
For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].
Dr. Marina Roytman
Department of Medicine
UCSF Fresno
Introducing Palliative Care (PC) within the treatment of End Stage Liver Disease (ESLD): A Cluster Randomized Controlled Trial (PAL-LIVER)
For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].
Dr. Marina Roytman
Department of Medicine
UCSF Fresno
A Randomized Double-blind Placebo-controlled Phase 3 Study to Evaluate the Effect of Resmetirom on Liver-related Outcomes in Patients with Well-compensated (Child-Pugh A) Non-alcoholic Steatohepatitis (NASH) Cirrhosis (MAESTRO-NASH OUTCOMES)
For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].
Dr. Marina Roytman
Department of Medicine
UCSF Fresno
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study To Assess The Efficacy and Safety of Rifaximin Soluble Sold Dispersion (SSD) Tablets For The Delay Of Encephalopathy Decompensation In Cirrhosis (RED-C)
For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].
Dr. Marina Roytman
Department of Medicine
UCSF Fresno
Expanded Access IND Protocol: Use of Tecovirimat (TPOXX) for treatment of Human Non- Variola Orthopoxvirus Infections in Adults and Children (STOMP)
For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].
Dr. Geetha Sivasubramanian
Infectious Disease
UCSF Fresno
Development of an Institution-Based Registry for Coccidioidomycosis: A Retrospective and Prospective Analysis to Inform Diagnoses, Treatment and Disease Burden in Fresno County (COCCI REGISTRY)
The purpose of this registry is to develop and utilize an institution-based registry to identify and study patients with clinically relevant coccidioidomycosis infections
Dr. Robert Libke Dr. Geetha Sivasubramanian Dr. Mohamed Fayed
Infectious Disease Infectious Disease Pulmonary Critical Care
UCSF Fresno UCSF Fresno UCSF Fresno
MIRAVISTA NEXT GENERATION COCCIDIOIDES IGG AND IGM ANTIBODY ENZYME IMMUNOASSAY EVALUATION
For more information about this trial, please contact the corresponding research coordinator, Alyssa Hughes at [email protected].
Dr. Geetha Sivasubramanian
Infectious Disease
UCSF Fresno
Regulatory T Cell Function in Predicting Valley Fever
For more information about this trial, please contact the corresponding research coordinator Yasmine Hernandez at [email protected]
Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis (Sands-PPC)
For more information about this trial, please contact the corresponding research coordinator Yasmine Hernandez at [email protected]
Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
DREAM: Discovering Cancer Risks from Environmental Contaminants and Maternal/Child Health (DREAM Cohort)
For more information about this trial, please contact the corresponding research coordinator Ashley Gutierrez at [email protected]
Dr. Amy Autry
Department of Obstetrics and Gynecology
UCSF Fresno
Residual Volume Reversibility in Asthma (ReVoReA) Study
The Residual Volume Reversibility in Asthma (ReVoReA) study compares the Performance of Spirometry and Lung Volume Reversibility Indices and their Association with Serum Inflammatory Markers in Asthmatics and Age-Gender Matched Normal Controls
Dr. Jose Vempilly
Department of Medicine
UCSF Fresno
A STUDY to evaluate the efficacy, safety, and tolerability of SAR440340/REGN3500/itepekimab (anti-IL-33 mAb)
For more information about this trial, please contact the corresponding research coordinator Adrian Torres at [email protected]
Dr. Vipal Jain
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
A REGISTRY FOR PATIENTS WHO HAVE RECEIVED EXTRACORPOREAL MEMBRANE OXYGENATION
Retrospective Review of Outcomes of all patients receiving ECMO following the inception of the ECMO Team
Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
Study Evaluating The Efficacy And Safety Of Vixarelimab Compared With Placebo In Patients With Idiopathic Pulmonary Fibrosis And In Patients With Systemic Sclerosis Associated Interstitial Lung Disease (MOONSCAPE)
For more information about this trial, please contact the corresponding research coordinator Yasmine Hernandez at [email protected]
Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
A Registry for the Lung Nodule Clinic
Lung Nodule Clinic Impact Study’s purpose is to examine the overall impact the Lung Nodule clinic has had in the Central valley in the detection of Lung cancer and connection of care.
Dr. Michael Peterson
Y. Frank and Roxie Moradian Chair in Medicine
UCSF Professor of Medicine
UCSF Fresno Associate Dean for UME and Research
Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of SPR720 as Compared with Placebo for the Treatment of Patients with Mycobacterium avium Complex (MAC) Pulmonary Disease
For more information about this trial, please contact the corresponding research coordinator Maria Hernandez at [email protected]
Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
A study to evaluate the Efficacy and Safety of an Amikacin Liposome Inhalation Suspension (ALIS)-Based Regimen in Adult Subjects with Newly Diagnosed Nontuberculous Mycobacterial (NTM) Lung Infection Caused by Mycobacterium avium Complex (MAC) (ENCORE)
For more information about this trial, please contact the corresponding research coordinator Maria Hernandez at [email protected]
Dr. Mohamed Fayed
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
ARTISAN (Afterload Reduction To Improve Right Ventricular Structure And FuNction)
For more information about this trial, please contact the corresponding research coordinator Sonia Garcia at [email protected]
Dr. Eyad Almasri
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
Retrospective study for the Evaluation of Pulmonary Arterial Hypertension (PAH) Patients
Retrospective Evaluation of Pulmonary Arterial Hypertension (PAH) Patients: Real-World Experience from the Trio Health Network
Dr. Eyad Almasri
Division of Pulmonary and Critical Care Medicine
UCSF Fresno
Post-Approval Study of the TREO Abdominal Stent- Graft System (P190015) in Patients with Infrarenal Abdominal Aortic and Aorto-iliac Aneurysms
For more information about this trial, please contact the corresponding research coordinator Adrian Torres at [email protected]
Dr. Sammy Siada
Department of Surgery
UCSF Fresno
Study of the Shockwave Medical Peripheral Intravascular Lithotripsy (IVL) System for Treatment of Calcified Peripheral Arterial Disease (PAD) in Below-the-Knee (BTK) Arteries
For more information about this trial, please contact the corresponding research coordinator Adrian Torres at [email protected]
Dr. Leigh Ann O’Banion
Department of Surgery
UCSF Fresno
